2-[3-(BROMOMETHYL)-4-FLUOROPHENYL]-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE, 95%, 250mg

(4-Formyl-cyclohexyl)-carbamic acid tert-butyl ester, 95.0%, 1g

4-(2-Methylimidazol-1-yl)-2,2-diphenylbutanenitrile, 98%, 250mg

Oxion Inverso OX.2453-PLPHF with LWD Plan fluarex 10x and plan phase fluarex 20x/40x objectives, 4-position filter blocks and XY cross table

BOC-3,5-difluoro-L-phenylalanine, 95.0%, 5g

(2-OXO-PIPERIDIN-4-YL)-CARBAMIC ACID TERT-BUTYL ESTER, 95.0%, 10g

Metilprednisolone, 95.0%, 5g

Methyl2-(4-benzyloxy-3-bromo-5-formyl-phenyl)acetate, 98%, 250mg

3-BROMO-7-FLUOROQUINOLINE, 95.0%, 5g

1-(Benzyloxy)-4-bromo-5-ethyl-2-fluorobenzene, 98%, 250mg

1-Methyl-4-(4-methylpiperidin-4-yl)piperazine trihydrochloride, 95+%, 250mg

2-Methylbenzenesulfonic acid hydrate, 97.0%, 25mg

Microliter syringe standard, 5 µl, 1 piece